Zobrazeno 1 - 10
of 76
pro vyhledávání: '"I M, Shevchuk"'
Publikováno v:
Клінічна хірургія, Vol 89, Iss 9-10, Pp 17-21 (2022)
Objective. To improve the results of surgical treatment in patients with postoperative peritonitis, using the certain algorithm proposed. Materials and methods. Prospective investigation was conducted on 244 patients, suffering postoperative perit
Externí odkaz:
https://doaj.org/article/675260bc115a4e65980047871254dbeb
Publikováno v:
Медицинский совет, Vol 0, Iss 4S, Pp 34-43 (2021)
Introduction. Simultaneous inhibition of programmed cell death-1 (PD-1)/PD-L1 immune checkpoint and VEGF/VEGFR signaling has a synergistic antitumor effect in preclinical models. This article presents the results of the phase III study JAVELIn Renal
Externí odkaz:
https://doaj.org/article/c3afb64476444a3dadcfbaff64f75b4a
Autor:
I. M. Shevchuk, S. S. Snizhko
Publikováno v:
Medičnì Perspektivi, Vol 25, Iss 3, Pp 132-139 (2020)
The goal of the work is to improve the results of treatment of patients with esophageal perforations complicated by purulent mediastinitis. Examination and treatment of 30 patients with esophageal perforation (EP) complicated by purulent mediastiniti
Externí odkaz:
https://doaj.org/article/935d97a0b2bb4d16abf87f778910499a
Publikováno v:
Cancer Urology. 19:169-177
Background. In the JAVELIN Bladder 100 trial, 1st line maintenance with avelumab in combination with best supportive care significantly increased (9.2 months) overall survival compared to best supportive care in patients with locally advanced or meta
Publikováno v:
Клінічна хірургія, Vol 86, Iss 2, Pp 3-8 (2019)
Мета. Покращити результати лікування хворих з низхідним гнійним медіастинітом (НГМ) шляхом удосконалення хірургічних доступів до серед
Externí odkaz:
https://doaj.org/article/a58961dd5de2428a8315ad9d74322586
Publikováno v:
Клінічна хірургія, Vol 85, Iss 11, Pp 13-17 (2018)
Мета. Покращити результати лікування хворих з перфорацією стравоходу (ПС), ускладненою гострим гнійним медіастинітом (ГГМ). Матеріали
Externí odkaz:
https://doaj.org/article/3e18bf46b28840f48e404fffbe0297cf
Autor:
B. Ya. Alekseev, I. M. Shevchuk
Publikováno v:
Cancer Urology. 18:51-59
Currently, combination immunotarget therapy is the treatment standard for patients with disseminated carcinoma of the renal parenchyma. Simultaneous inhibition of immune checkpoints of programmed cell death 1 (PD-1)/PD-L1 and VEGF/VEGFR signal transd
Autor:
B. Ya. Alekseev, I. M. Shevchuk
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 70-76 (2018)
Pazopanib (Votrient®) is an oral small-molecule multi-kinase inhibitor that predominantly inhibits vascular endothelial growth factor receptor-1, -2 and -3, platelet-derived growth factor receptor-α and -β and the stem cell factor receptor c-Kit.
Externí odkaz:
https://doaj.org/article/18e7236782a74f9797bb36a042fde636
Autor:
K. M. Nyushko, B. Ya. Alekseev, V. M. Perepukhov, I. M. Shevchuk, V. A. Atduev, А. B. Zdobnikov, V. B. Venskel, Е. V. Gurin, A. V. Eremenko, I. V. Belov, V. D. Gavrilova, R. M. Ismakov, D. G. Prokhorov, R. V. Nikitin, E. A. Usinin, E. I. Kopyltsov, O. V. Leonov, А. O. Leonov
Publikováno v:
Cancer Urology. 18:102-110
Background. Prostate cancer (PCa) is an actual disease and a frequent oncological pathology in men. The main methods of radical treatment of patients with PCa are radical prostatectomy and radiation therapy. Radical prostatectomy s the most commonly
Autor:
M. Yu. Prosyannikov, A. D. Kaprin, O. I. Apolikhin, B. Ya. Alekseev, A. V. Sivkov, I. M. Shevchuk, D. A. Voytko, N. V. Anokhin
Publikováno v:
Cancer Urology. 18:190-197
Recently, there has been a worldwide increase in the incidence of bladder cancer. Improved morphological diagnostics, increased surgical activity and availability of chemotherapy allowed reducing the one-year mortality rate and increasing the five-ye